Burnout: Evaluation of the efficacy and tolerability of TARGET 1(R) for professional fatigue syndrome (burnout)

Conclusions
TARGET 1® significantly improved the symptoms of burnout after 12 weeks’ use.

Source: Journal of International Medical Research - January 30, 2015 Category: Research Authors: Jacquet, A., Grolleau, A., Jove, J., Lassalle, R., Moore, N. Tags: Research Reports Source Type: research